Search

Author/Creator Mu, Xinmeng Jasmine

1. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Issue 1 (January 2022)

Authors:
Naranbhai, Vivek; Viard, Mathias; Dean, Michael; Groha, Stefan; Braun, David A; Labaki, Chris; Shukla, Sachet A; Yuki, Yuko; Shah, Parantu; Chin, Kevin; Wind-Rotolo, Megan; Mu, Xinmeng Jasmine; Robbins, Paul B; Gusev, Alexander; Choueiri, Toni K; Gulley, James L; Carrington, Mary
Journal:
Lancet oncology
Issue:
Volume 23:Issue 1(2022)
Page Start:
172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. (3rd July 2018)

Authors:
Hamada, Tsuyoshi; Soong, Thing Rinda; Masugi, Yohei; Kosumi, Keisuke; Nowak, Jonathan A.; da Silva, Annacarolina; Mu, Xinmeng Jasmine; Twombly, Tyler S.; Koh, Hideo; Yang, Juhong; Song, Mingyang; Liu, Li; Gu, Mancang; Shi, Yan; Nosho, Katsuhiko; Morikawa, Teppei; Inamura, Kentaro; Shukla, Sachet ...
Journal:
Oncoimmunology
Issue:
Volume 7:Number 7(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search